Alza Hit With Class Action Lawsuit Over Ditropan XL

Law360, New York (March 1, 2006, 12:00 AM EST) -- Johnson & Johnson subsidiary Alza Corporation has been smacked with a class-action antitrust lawsuit, accusing the unit of illegally trying to keep generic versions of overactive bladder drug Ditropan XL off the shelf.

The suit, filed last Wednesday in U.S. District Court for the Northern District of California by the Teamsters Local No. 35 Health Plan, charged the Big Pharma with unfairly shutting competitors out of the marketplace.

“The result of the defendant’s unlawful conduct has been to obtain and extend their monopoly,” the complaint alleged....
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.